A detailed history of Tower Research Capital LLC (Trc) transactions in Organon & Co. stock. As of the latest transaction made, Tower Research Capital LLC (Trc) holds 9,669 shares of OGN stock, worth $145,325. This represents 0.01% of its overall portfolio holdings.

Number of Shares
9,669
Previous 1,725 460.52%
Holding current value
$145,325
Previous $35,000 425.71%
% of portfolio
0.01%
Previous 0.0%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$18.65 - $23.03 $148,155 - $182,950
7,944 Added 460.52%
9,669 $184,000
Q2 2024

Aug 13, 2024

SELL
$17.45 - $21.96 $61,912 - $77,914
-3,548 Reduced 67.29%
1,725 $35,000
Q1 2024

May 15, 2024

SELL
$13.78 - $18.8 $97,810 - $133,442
-7,098 Reduced 57.38%
5,273 $99,000
Q4 2023

Feb 13, 2024

SELL
$10.95 - $17.32 $159,114 - $251,676
-14,531 Reduced 54.01%
12,371 $178,000
Q3 2023

Nov 14, 2023

BUY
$16.59 - $23.77 $261,922 - $375,280
15,788 Added 142.06%
26,902 $467,000
Q2 2023

Aug 14, 2023

BUY
$19.27 - $24.63 $157,763 - $201,645
8,187 Added 279.71%
11,114 $231,000
Q1 2023

May 09, 2023

SELL
$21.42 - $32.08 $33,522 - $50,205
-1,565 Reduced 34.84%
2,927 $69,000
Q4 2022

Feb 10, 2023

SELL
$23.31 - $28.61 $1.16 Million - $1.42 Million
-49,647 Reduced 91.7%
4,492 $126,000
Q3 2022

Nov 10, 2022

BUY
$23.4 - $34.25 $918,707 - $1.34 Million
39,261 Added 263.89%
54,139 $1.27 Million
Q2 2022

Aug 15, 2022

SELL
$31.66 - $38.9 $658,306 - $808,847
-20,793 Reduced 58.29%
14,878 $502,000
Q1 2022

May 12, 2022

BUY
$30.45 - $39.36 $615,607 - $795,741
20,217 Added 130.82%
35,671 $1.25 Million
Q4 2021

Feb 14, 2022

BUY
$28.67 - $37.13 $135,781 - $175,847
4,736 Added 44.19%
15,454 $471,000
Q3 2021

Nov 15, 2021

SELL
$28.63 - $35.64 $216,729 - $269,794
-7,570 Reduced 41.39%
10,718 $351,000
Q2 2021

Aug 16, 2021

BUY
$28.45 - $38.0 $520,293 - $694,944
18,288 New
18,288 $554,000

Others Institutions Holding OGN

About Organon & Co.


  • Ticker OGN
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 254,330,000
  • Market Cap $3.82B
  • Description
  • Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio...
More about OGN
Track This Portfolio

Track Tower Research Capital LLC (Trc) Portfolio

Follow Tower Research Capital LLC (Trc) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tower Research Capital LLC (Trc), based on Form 13F filings with the SEC.

News

Stay updated on Tower Research Capital LLC (Trc) with notifications on news.